A patient with chronic lymphocytic leukemia (CLL) will imminently begin a course of treatment with rituximab. In order to minimize the risk of adverse effects, what strategy for administration will be adopted?
A) Admitting the patient to the intensive care unit in anticipation of the initial bolus of the drug
B) Administering diphenhydramine 30 minutes prior to the initial dose of rituximab
C) Administering the drug by slow infusion to two peripheral IV sites simultaneously
D) Administering the initial doses by slow infusion while observing for adverse reactions
Question 2
A nurse has completed a medication reconciliation of a patient who has been admitted following a motor vehicle accident. Among the many drugs that the patient has received in the previous year is rituximab.
The nurse would be justified in suspecting the patient may have received treatment for which of the following diseases?
A) Non-Hodgkin's lymphoma
B) Malignant melanoma
C) Nonsmall cell lung cancer
D) Renal cell carcinoma
Measuring Patient Height
Patient teaching: female genetalia and reproductive tract assessment
Immediate Treatment of an MI
Patient Information Supplied When Scheduling Hospital Admissions
Digital recording devices can be helpful when providing patient education to visually impaired ...
IgG after treatment with pepsin.